Tuberculosis patient adherence to direct observation: Results of a social study in Pakistan

Health Policy and Planning

Volumn 20, Issue 6, 2005, Pages 354-365

  Khan, M A ^a,f,g   Walley, J D ^b,h   Witter, S N ^c   Shah, S K ^d,i   Javeed, S ^e  

^a Association for Social Development   (Pakistan)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d National TB Control Programme   (Pakistan)

^e Freelance Consultant ^*  (Pakistan)

^f DFID funded Tuberculosis Research Programme

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h Leeds TB Research and Development Programme   (United Kingdom)

ⁱ Stop TB Partnership

Author keywords

Direct observation; DOTS; Pakistan; Patient adherence; Tuberculosis

Indexed keywords

CLINICAL OBSERVATION; ECONOMIC ASPECT; FEMALE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PERSONNEL ATTITUDE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PAKISTAN; PATIENT COMPLIANCE; REVIEW; SOCIOLOGY; TIME; TRAVEL; TUBERCULOSIS;

DATA COLLECTION; FEMALE; HUMANS; MALE; OBSERVATION; PAKISTAN; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS; SOCIAL SCIENCES; TUBERCULOSIS;

EID: 27644524096     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czi047     Document Type: Review

References (15)

1. Escott S, Walley J. Listening to those on the frontline: lessons for community-based TB programme from a qualitative study in Swaziland. Social Science and Medicine, forthcoming.
2. Floyd K, Wilkinson D, Gilks C. 1997. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. British Medical Journal 315: 1407-11.
3. Kamolratanakul P, Sawert H, Lertmaharit S et al. 1999. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93: 552-7.
4. Khan A, Walley J, Newell J, Imdad N. 2000. Tuberculosis in Pakistan: socio-cultural constraints and opportunities in treatment. Social Science and Medicine 50: 247-54.
5. Khan MA, Walley JD, Witter SN, Imran A, Safdar N. 2002. Costs and cost effectiveness of different DOTS strategies for treatment of tuberculosis: economic results of a randomized controlled trial in Pakistan. Health Policy and Planning 17: 178-86.
6. Porter J, Grange J (eds). 1999. Tuberculosis - an interdisciplinary perspective. London: Imperial Press.
7. Singh V, Jaiswal A, Porter JD et al. 2002. TB control, poverty and vulnerability in Delhi, India. Tropical Medicine and International Health 7: 693-700.
8. Volmink J, Garner P. 2002. Directly observed therapy for treating tuberculosis. The Cochrane Library. The Cochrane Collaboration (Issue 3). Update software.
9. Volmink J, Matchaba P, Garner P. 2000. Directly observed therapy and treatment adherence. The Lancet 355: 1345-50.
10. Walley J, Amir Khan M, Newell J, Hussain Khan M. 2001. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. The Lancet 357: 664-9.
11. WHO. 2002. An expanded DOTS framework for effective TB control, 2002. Geneva: World Health Organization.
12. WHO. 2003. Treatment of tuberculosis: guidelines for national programmes (3rd edition). Geneva: World Health Organization.
13. Wilkinson D, Davies G. 1997. Coping with Africa's increasing tuberculosis burden: are community supervisors an essential component of the DOT strategy? Tropical Medicine and International Health 2: 700-4.
14. Wright J, Walley J, Philip A et al. 2004. Direct observation of treatment for tuberculosis: a randomised controlled trial of community health workers versus family members. Journal of Tropical Medicine and International Health 9: 559-65.
15. Zwarenstein M, Schoeman J, Vundule C, Lombard C, Tatley M. 2000. A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis. International Journal of Tuberculosis and Lung Disease 4: 550-4.